Concepedia

Yang‐Min Ning

YN

Statistics

Publications

28

Citations

3K

H-Index

23

Active since

1993

Affiliations

United States Food and Drug Administration(Current)

National Cancer Institute

Center for Drug Evaluation and Research

Center for Cancer Research

National Institutes of Health

Yang‐Min Ning is an author at United States Food and Drug Administration specializing in medicine, oncology, and pharmacology.

Publications per year

1993–2020

28

Publications

28

A New First Step in Activation of Steroid Receptors

Todd H. Davies, Yang‐Min Ning, Edwin R. Sánchez · Journal of Biological Chemistry · 2002 · 428 citations · Full text

, , +17

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody

V. Ellen Maher, Laura L. Fernandes, Chana Weinstock et al. · Journal of Clinical Oncology · 2019 · 346 citations

, , +17

Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy

Wilfred D. Stein, James L. Gulley, Jeff Schlom et al. · Clinical Cancer Research · 2010 · 247 citations · Full text

, , +17

FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy

Daniel L. Suzman, Sundeep Agrawal, Yang‐Min Ning et al. · The Oncologist · 2018 · 200 citations · Full text

, , +15

Differential Control of Glucocorticoid Receptor Hormone-Binding Function by Tetratricopeptide Repeat (TPR) Proteins and the Immunosuppressive Ligand FK506

Todd H. Davies, Yang‐Min Ning, Edwin R. Sánchez · Biochemistry · 2005 · 183 citations

, , +17

1–5 of 28